Avinger Net Common Equity Issued/Repurchased 2013-2024 | AVGR
Avinger net common equity issued/repurchased from 2013 to 2024. Net common equity issued/repurchased can be defined as the net dollar amount of transactions to issue and repurchase common stock.
| Avinger Annual Net Common Equity Issued/Repurchased (Millions of US $) |
|
|---|---|
| 2023 | $5 |
| 2022 | $5 |
| 2021 | $13 |
| 2020 | $24 |
| 2019 | $12 |
| 2018 | $14 |
| 2017 | $4 |
| 2016 | $37 |
| 2015 | $64 |
| 2014 | $0 |
| 2013 | $0 |
| 2012 | $0 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | MED INSTRUMENTS | $0.002B | $0.008B |
| Avinger, Inc. is engaged in designing, manufacturing and selling image-guided, catheter-based systems to treat peripheral arterial disease. The company's product consists of Lightbox imaging console, Wildcat, Kittycat, Ocelot, Ocelot PIXL, Ocelot MVRX and Juicebox. Avinger, Inc. is based in Redwood City, California. | |||